Ukrainian FemTech Startup Ovul Selected for CES 2026 National Delegation

AI-Powered Women’s Health Platform Represents Ukraine’s Growing Tech Innovation on Global Stage

Ovul, an artificial intelligence-powered women’s health technology company, has been selected by Ukraine’s Ministry of Technology to represent the nation’s innovation ecosystem at the 2026 Consumer Electronics Show (CES) in Las Vegas.

Ovul is one of eight startups chosen for Ukraine’s official delegation to the world’s largest technology exhibition, scheduled for January 2026. The selection recognizes Ovul’s rapid growth trajectory and breakthrough approach to hormone monitoring.

Platform Expansion Drives Selection

The Ministry’s choice comes as Ovul transitions from a fertility-focused solution to a comprehensive hormonal health platform.Originally launched as a fertility and ovulation tracking solution, Ovul recently expanded its platform to include perimenopause and menopause support, significantly expanding its addressable market to include the estimated 1.3 billion women worldwide who will experience menopause by 2030.

“This nomination comes at a pivotal moment for Ovul,” said Kateryna Andreeva, Co founder of Ovul. “We recently rolled out in app perimenopause support functionality, allowing us to serve an entirely new and vast user population. CES is the ideal platform to demonstrate how simple at home hormone monitoring can be, while also showcasing our newly trained AI menopause support features.”

Science-Backed Technology

Ovul’s platform combines a reusable, saliva-based at-home device with proprietary AI algorithms to analyze hormone-related patterns. Unlike traditional methods requiring consumables or invasive testing, the technology provides daily hormone trend data through a simple, non-invasive process. Over the past year, the company has significantly grown its user base and proprietary dataset, strengthening its AI models and accelerating product development across multiple stages of hormonal health.

In addition to commercial growth, Ovul recently achieved a major scientific milestone with the publication of peer reviewed validation research in the National Library of Medicine, reinforcing the credibility of its technology and underlying methodology.

“We are honored that Ovul has been chosen to represent Ukraine’s vibrant innovation landscape,” said Serhii Zatsarynin, PhD, CEO of Ovul. “This recognition highlights how far we have come in a very short period of time and reflects our team’s ability to execute, adapt, and consistently deliver on our vision. It is a powerful example of what focused determination and strong technical leadership can achieve.”

Ukraine’s Tech Ecosystem on Display

At CES 2026, Ovul will exhibit within the Ukrainian Pavilion in the Global Pavilions section, presenting its technology to international investors, healthcare partners, and media. The company’s participation underscores Ukraine’s emergence as a hub for health technology innovation and applied artificial intelligence, demonstrating the resilience of the nation’s tech sector.

The Consumer Electronics Show attracts over 130,000 attendees annually and serves as a launching pad for emerging technologies seeking global market penetration.

---

About Ovul

Ovul is a women’s health technology company focused on accessible, AI powered hormone monitoring. The Ovul platform combines a saliva based at home device with intelligent software to deliver personalized insights across fertility, ovulation, perimenopause, and menopause. Designed for daily use, Ovul empowers users with meaningful hormone trend data while continuously improving through a growing real world dataset and peer reviewed science.